Clinical Trial: Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07079410) titled 'Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma' on July 04.

Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of the combination therapy of immunotherapy (Sintilimab) with targeted therapy (Cetuximab) as a possible treatment before and after surgery for locally advanced oral/pharyngeal squamous cell carcinoma.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Oral Squamous Cell Carcinoma (OSCC) Oropharyngeal Squamous Cell Carcinoma Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Intervention: DRU...